Assessment of Knowledge of Patients Regarding Human Papillomavirus in A Tertiary Hospital
DOI:
https://doi.org/10.33719/sexscij.2504.9Keywords:
cervical cancer, human papillomavirus, HPV vaccine, women’s health, pap smearAbstract
Objective: Human Papillomavirus (HPV) is a risk factor for cervical, vulvar, and vaginal cancers. HPV vaccination is used for immunization against this virus. This study aims to determine the knowledge level of patients admitted to our outpatient clinic regarding HPV and the HPV vaccine.
Materials and Methods: The sample of this cross-sectional study comprised 1,225 women admitted to our gynecology outpatient clinics between January 1, 2013, and June 31, 2013. We collected data on sociodemographic characteristics, level of HPV and cervical cancer knowledge, awareness of Pap smear testing, and self-reported previous Pap smear tests through a questionnaire.
Results: The mean age of participants was 37.79±13.19 (range 15–73). Of these participants, 31.8% had previously undergone a Pap smear, 62.4% had heard of cervical cancer, and 60.5% were aware of Pap smear testing. Television programs emerged as the leading source (24.7%) for HPV information. Notably, 65.7% of participants did not know that HPV can be sexually transmitted. Meanwhile, 60.5% had not heard of the HPV vaccine, and 70.5% were unaware that HPV vaccination can help prevent cervical cancer. Among participants who had received the vaccine, 63.3% stated they would encourage their daughters to get vaccinated.
Conclusion: Our findings suggest that women’s knowledge about HPV infection and vaccination remains insufficient. Efforts focusing on improving awareness of HPV and the HPV vaccine among the female population, particularly via healthcare providers, are critically important to achieving healthier future generations.
References
1. Schiffman, M., Doorbar, J., Wentzensen, N. de Sanjosé, S., Fakhry, C., Monk, B.J., Stanley, M.A., Franceschi, S. (2016). Carcinogenic human papillomavirus infection. Nat Rev Dis Primers, 2, 16086. https://doi.org/10.1038/nrdp.2016.86
2. Viens, L.J., Henley, S.J., Watson, M., Markowitz, L.E., Thomas, C.C., Thompson, T.D., Razzaghi, H., Saraiya, M. (2016). Human Papillomavirus-Associated Cancers - United States, 2008-2012. MMWR Morb Mortal Wkly Rep, 65(26), 661-666. https://doi.org/10.15585/mmwr.mm6526a1
3. Seyferth, Elisabeth R., Bratic, Julia S., Bocchini, Joseph A. Jr. (2016). Human papillomavirus epidemiology and vaccine recommendations: selected review of the recent literature. Current Opinion in Pediatrics, 28(3), 400-406. https://doi.org/10.1097/MOP.0000000000000354
4. Stanley, M. (2020). Immune Responses to Human Papillomavirus and the Development of Human Papillomavirus Vaccines. Human Papillomavirus: Elsevier, 283-297.
5. Phillips, A., Patel, C., Pillsbury, A., Brotherton, J., Macartney, K. (2018). Safety of Human Papillomavirus Vaccines: An Updated Review. Drug Saf, 41(4), 329-346. https://doi.org/10.1007/s40264-017-0625-z
6. Stanley, M. (2016). Human papillomavirus vaccines. The Vaccine Book: Elsevier, 245-263.
7. Harden, M.E., Munger, K. (2017). Human papillomavirus molecular biology. Mutat Res Rev Mutat Res, 772, 3-12. https://doi.org/10.1016/j.mrrev.2016.07.002
8. Bruni, L., Diaz, M., Barrionuevo-Rosas, L., Herrero, R., Bray, F., Bosch, F.X., de Sanjosé, S., Castellsagué, X. (2016). Global estimates of human papillomavirus vaccination coverage by region and income level: a pooled analysis. Lancet Glob Health, 4(7), 453-463. https://doi.org/10.1016/S2214-109X(16)30099-7
9. Kavanagh, K., Pollock, K.G., Cuschieri, K., Palmer, T., Cameron, R.L., Watt, C., Bhatia, R., Moore, C., Cubie, H., Cruickshank, M., Robertson, C. (2017). Changes in the prevalence of human papillomavirus following a national bivalent human papillomavirus vaccination programme in Scotland: a 7-year cross-sectional study. Lancet Infect Dis, 17(12), 1293-1302. https://doi.org/10.1016/S1473-3099(17)30468-1
10. Eckhardt, M., Zhang, W., Gross, A.M., Von Dollen, J., Johnson, J.R., Franks-Skiba, K.E., Swaney, D.L., Johnson, T.L., Jang, G.M., Shah, P.S., Brand, T.M., Archambault, J., Kreisberg, J.F., Grandis, J.R., Ideker, T., Krogan, N.J. (2018). Multiple Routes to Oncogenesis Are Promoted by the Human Papillomavirus-Host Protein Network. Cancer Discov, 8(11), 1474-1489. https://doi.org/10.1158/2159-8290.CD-17-1018
11. de Sanjosé, S., Brotons, M., Pavón, M.A. (2018). The natural history of human papillomavirus infection. Best Pract Res Clin Obstet Gynaecol, 47, 2-13. https://doi.org/10.1016/j.bpobgyn.2017.08.015
12. Zemheri, E., Koyuncaer, A. (2005). Servikal kanserlerin erken tanısında pap testinin onemi. Sürekli Tıp Egitimi Dergisi, 14, 2-3.
13. Gichangi, P., Estambale, B., Bwayo, J., Rogo, K., Ojwang, S., Opiyo, A., Temmerman, M. (2003). Knowledge and practice about cervical cancer and Pap smear testing among patients at Kenyatta National Hospital, Nairobi, Kenya. Int J Gynecol Cancer, 13(6), 827-833. https://doi.org/10.1111/j.1525-1438.2003.13612.x.
14. Tarwirei, F., Chirenje, Z., Rusakaniko, S. (2003). Cancer of the cervix: knowledge, beliefs and screening behaviours of health workers in Mudzi District in Mashonaland East Province, Zimbabwe. 2003.
15. Kalyoncu, C., Işıklı, B., Özalp, S., Küçük, N. (2003). Osmangazi Üniversitesi kadın hastalıkları ve doğum polikliniğine başvuranların pap smear hakkında bilgi tutum ve davranışları. Sağlık ve Toplum, 13, 60-66.
16. Wellensiek, N., Moodley, M., Moodley, J., Nkwanyana, N. (2002). Knowledge of cervical cancer screening and use of cervical screening facilities among women from various socioeconomic backgrounds in Durban, Kwazulu Natal, South Africa. Int J Gynecol Cancer, 12(4), 376-382. https://doi.org/10.1046/j.1525-1438.2002.01114.x
17. Güngör, M., Güngör, L., Açık, Y., Oguzöncül, F. (2001). Elazıg Devlet Hastanesi’nde görev yapan evli, hamile olmayan hemsire, ebe ve bayan saglık teknisyenlerinde Pap Smear taraması. Fırat Üniversitesi Saglık Bilimleri Dergisi, 15, 471-476.
18. Oran, N., Oztürk, H., Ergün, F. Mammography and Pap-Smear behaviours among academicians. The First Regional Meeting of the APOCP, 42003:42050.
19. Akyüz, A., Güvenç, G., Yavan, T., Çetintürk, A., Kök, G. (2006). Kadınların pap smear yaptırma durumları ile bunu etkileyen faktörlerin belirlenmesi. Gülhane Tıp Dergisi, 48, 25-29.
20. Shapiro, G.K. (2022). HPV Vaccination: An Underused Strategy for the Prevention of Cancer. Curr Oncol, 29(5), 3780-3792. https://doi.org/10.3390/curroncol29050303
21. Kwella, H., Schilbert, J., Tessartz, A., Scheersoi, A. (2025). From classrooms to real-world contexts: enhancing vaccine education through open schooling. Frontiers in Public Health, 13, 1520395.
22. Zaidi, A.R.Z., Alghalyini, B. 82024). Comment on “Racial and ethnic disparities in human papillomavirus (HPV) vaccine uptake among United States adults, aged 27-45 years”. Hum Vaccin Immunother, 20(1), 2369361. https://doi.org/10.1080/21645515.2024.2369361
23. Esposito, S., Bosis, S., Pelucchi, C., Begliatti, E., Rognoni, A., Bellasio, M., Tel, F., Consolo, S., (2007). Principi N. Pediatrician knowledge and attitudes regarding human papillomavirus disease and its prevention. Vaccine, 25(35), 6437-6446. https://doi.org/10.1016/j.vaccine.2007.06.053
24. Metindir, J. (2007). Servikal Kanser Kontrolünde Human Papilloma Virüs İnfeksiyonlarına Karşı Aşılama. Acta Oncologica Turcica, 40, 5-10.
25. Kurtipek, G.S., Cihan, F.G., Ataseven, A., Özer, I., Turhan, Z.C. (2016). On Sekiz Yas Üzeri Kadinlarin Genital Verru, Servikal Kanser ve Human Papilloma Virüs Asisi Hakkinda Bilgi, Tutum ve Davranislari/The Knowledge, Attitude and Behaviours of Women above 18 Years Old about Genital Warts, Cervical Cancer and Human Papilloma Virus Vaccination. Turk Dermatoloji Dergisi, 10, 105.
26. Daley, M.F., Liddon, N., Crane, L.A., Beaty, B.L., Barrow, J., Babbel, C., Markowitz, L.E., Dunne, E.F., Stokley, S., Dickinson, L.M., Berman, S., Kempe, A. (2006). A national survey of pediatrician knowledge and attitudes regarding human papillomavirus vaccination. Pediatrics, 118(6), 2280-2289. https://doi.org/10.1542/peds.2006-1946
27. Yetimalar, H., Koksal, A., Kasap, B., Uysal, A., Çukurova, K. (2009). Current approach of health employees in Turkey to pap smear test. J Turkish-German Gynecol Assoc, 10, 68-70.
28. Çetin, O., Verit, F.F., Keskin, S., Zebitay, A.G., Deregözü, A., Usta, T., et al. (2014) Ergen kızların human papilloma virüsü ve aşısı hakkındaki bilgi düzeyleri. Türk Ped Arş, 49, 142-147.
29. Waheed, D.E., Bolio, A., Guillaume, D., Sidibe, A., Morgan, C., Karafillakis, E., Holloway, M., Van Damme, P., Limaye, R., Vorsters, A. (2023). Planning, implementation, and sustaining high coverage of human papillomavirus (HPV) vaccination programs: What works in the context of low-resource countries? Front Public Health, 11, 1112981. https://doi.org/10.3389/fpubh.2023.1112981
30. Raley, J.C., Followwill, K.A., Zimet, G.D., Ault, K.A. (2004). Gynecologists’ attitudes regarding human papilloma virus vaccination: a survey of Fellows of the American College of Obstetricians and Gynecologists. Infect Dis Obstet Gynecol, 12(3-4), 127-33. https://doi.org/10.1080/10647440400020661
31. Guillaume, D., Waheed, D.E., Schleiff, M., Muralidharan, K.K., Vorsters, A., Limaye, R.J. (2024). Global perspectives of determinants influencing HPV vaccine introduction and scale-up in low- and middle-income countries. PLoS One, 19(1), e0291990. https://doi.org/10.1371/journal.pone.0291990.
Downloads
Published
How to Cite
License
Copyright (c) 2025 Nurgul Ulusoy, Hediye AGDEVIREN , Ender GUVEN
This work is licensed under a Creative Commons Attribution 4.0 International License.
